Ratings by Ascendiant Capital (Lucas Ward)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/3/2025 | Vivos Therapeutics | VVOS | Maintain | Buy (N/A) |
|
Details | ||
| 9/19/2025 | Aclarion, Inc. | ACON | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2025 | 60 Degrees Pharmaceuticals Inc | SXTP | Maintain | Buy (N/A) |
|
Details | ||
| 5/30/2025 | Aclarion, Inc. | ACON | Maintain | Buy (N/A) |
|
Details | ||
| 11/27/2024 | Aclarion, Inc. | ACON | Maintain | Buy (N/A) |
|
Details | ||
| 8/26/2024 | Cyclo Therapeutics | CYTH | Maintain | Buy (N/A) |
|
Details | ||
| 8/20/2024 | Vivos Therapeutics | VVOS | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2024 | Vision Marine Technologies Inc. | VMAR | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2024 | Aclarion, Inc. | ACON | New Coverage | Buy (N/A) |
0.31 (3.27) |
954.84% | Details | |
| 5/21/2024 | 60 Degrees Pharmaceuticals Inc | SXTP | Maintain | Buy (N/A) |
|
Details | ||
| 4/22/2024 | Cyclo Therapeutics | CYTH | New Coverage | Buy (N/A) |
1.20 (0.72) |
-40% | Details | |
| 2/26/2024 | LiqTech International | LIQT | New Coverage | Buy (N/A) |
3.13 (1.42) |
-54.63% | Details | |
| 1/29/2024 | Vision Marine Technologies Inc. | VMAR | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2023 | Vision Marine Technologies Inc. | VMAR | New Coverage | Buy (N/A) |
1.98 (2.39) |
20.71% | Details | |
| 10/2/2023 | 60 Degrees Pharmaceuticals Inc | SXTP | New Coverage | Buy (N/A) |
0.74 (2.05) |
177.03% | Details | |
| 6/15/2023 | Vivos Therapeutics | VVOS | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2023 | ShiftPixy Inc | PIXY | New Coverage | Buy (N/A) |
5.11 (6.53) |
27.79% | Details |
